RxDoctor Payments Data

Hazel Marecki, MD

Vascular Surgery · Springfield, MANPI 1992237523

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (41.8%), grants and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Bolton Medical Inc at 32.5% of the total. Reporting peaked in 2024 at $2,613 and has fallen 84.0% since, to $418 in 2025.

$6,314in general payments, 2019–2025

Across 40 payments — averaging $157.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bolton Medical Inc$2K
  • Cook Medical LLC$1K
  • Getinge USA Sales, LLC$1K
  • Silk Road Medical, Inc.$504
  • Endologix LLC$227
  • W. L. Gore & Associates, Inc.$185
  • plus $1K from 10 others

What the payments were for

  • Grants$2,14834%
  • Travel & lodging$1,52824%
  • Food & beverage$2,63942%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,314 in reported general payments places this provider in the 60th percentile of 142 vascular surgery providers in Massachusetts.

See all vascular surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$239,288
Medicare patients
758
Services billed
1,627

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban63$43,121
XareltoRivaroxaban51$36,289
Atorvastatin Calcium41$531
ClopidogrelClopidogrel Bisulfate32$514
Lidocaine-PrilocaineLidocaine/Prilocaine23$302
Nifedipine ErNifedipine14$179
Hydromorphone Hcl15$144
Oxycodone Hcl24$124
Lorazepam29$76
Amlodipine Besylate12$32

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Springfield

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →